In an interview with PharmaShots, Monica Mann, Vice President, Medical Affairs for Global MS and Pipeline at Biogen shared her views on the data of Tysabri, Vumerity & highlights of new digital health research to predict multiple sclerosis disease progression
Shots:
Monica spoke about detailed results of the new real-world & clinical data on the long-term use of Tysabri & real-world analyses…
